The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 2133-2136

  Sun, Shung Shung ^a   Hsieh, Jih Fang ^b   Tsai, Shih Chuan ^c   Ho, Yung Jen ^d   Lee, Jong Kang ^a   Kao, Chia Hung ^e  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI FOUNDATION HOSPITAL   (Taiwan)

^c SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^d JEN AI HOSPITAL   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Mammography; Scintimammography; Taiwanese women; Tc 99m methoxyisobutyliscinitrile

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CLINICAL TRIAL; DEVICE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; FILM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; TAIWAN;

ADULT; AGED; BREAST; BREAST DISEASES; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; EVALUATION STUDIES; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TAIWAN; TECHNETIUM TC 99M SESTAMIBI;

EID: 0033884313     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Alagaratnam TT and Wong J: Limitations of mammography in Chinese Females. Clin Radiol 36: 175-177, 1985.
2. Piwnica-Worms D, Kronauge JF and Chiu ML: Uptake and retention of hexakis (2- methoxyisobutyl isonitrile) technetium (1) in cultured chick myocardial cells. Mitochondrial and plasma menbrane potential dependence. Circulation 82: 1826-1838, 1990.
3. Beller GA and Watson DD: Physiological basis of myocardial perfusion imaging with the technetium 99m agents. Semin Nucl Med 21: 173-181, 1991.
4. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL and Piwnica-Worms D: Celluar distribution and analysis of Tc-99m MIBI in isolated perfused rat hearts. J Nucl Med 33: 1516-1521, 1992.
5. Muller ST, Guth-Tougelids B and Creutzig GH: Imaging of malignant tumors with Tc-99m MIBI SPECT. Eur J Nucl Med 28: 562P, 1987.
6. Hassan I, Sahweil A, Constantinindes C, Mahmoud A, Nair M, Omar YT and Abdel-Dayem HM: Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 14: 333-340, 1989.
7. Aktolun C, Bayhan H and Kir M: Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors: preliminary results and comparison with TI-201. Clin Nucl Med 17: 171-176, 1992.
8. Yuen-Green M, Wasnich R, Caindec-Ranchez S and Davis J: New method for breast cancer detection using Tc-99m sestamibi scintimammography. Hawaii Med J 55: 26-28, 1996.
9. Taillefer R: The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med 29: 16-40, 1999.
10. Cwikla JB, Buscombe JR, Kelleher SM, Parbhoo SP, Thakrar DS, Hinton J, Deery AR, Crow J and Hilson AJ: Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy. Clin Radiol 53: 274-280, 1998.
11. Clifford EJ and Lugo-Zamudio C: Scintimammography in the diagnosis of breast cancer. Am J Surg 772: 483-486, 1996.
12. Burak Z, Argon M, Memis A, Erdem S, Balkan Z, Duman Y, Ustun EE, Erhan Y and Ozkkilic H: Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 5: 604-612, 1994.
13. Kao CH, Wang SJ and Liu TJ: The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 21: 432-436, 1994.
14. Garcia-Fernandez R, Maravilla A, Pichardo-Romero P, Rubio V, Iwasaki-Otake L and Arevila-Ceballos N: Diagnosis of breast tumors by scintigraphy versus mammography. Rev Invest Clin 50: 53-56, 1998.
15. Khalkhali I, Mena I, Jouanne E, Diggles L, Venegas R, Block J, Alle K and Klein S: Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 178: 491-497, 1994.
16. Prats E, Abos M, Aisa F, Villavieja L, Asenjo M, Garcia-Lopez F, Tomas A, Sainz J, Razola P and Banzo J: Gammography using Tc 99m MIBI in patients with suspected breast cancer. Proposed diagnostic protocol. Rev Esp Med Nucl 17: 73-81, 1998.
17. Flanagan DA, Gladding SB and Lovell FR: Can sGintimammography reduce "unnecessary" biopsies? Am Surg 64: 670-673, 1998.
18. Uriarte I, Carril JM, Quirce R, Gutierrez-Mendiguchia C, Blanco I, Banzo I, Vega A and Hernandez A: Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions. Eur J Nucl Med 25: 491-496, 1998.
19. Carril JM, Gomez-Barquin R, Quirce R, Tahuenca O, Uriarte I and Montero A: Contribution of 99mTc-MIBI scintimammography to the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy. Anticancer Res 17: 1677-1681, 1997.
20. Scopinaro F, Ierardi M, Porfiri LM, Tiberio NS, De-Vincentis G, Mezi S, Cannas d P, Gigliotti T and Marzetti L: 99mTc-MIBI prone scintimammography in patients with high and intermediate risk mammography. Anticancer Res 17: 1635-1638, 1997.
21. Palmedo H, Schomburg A, Grunwald F, Mallmann P, Boldt I and Biersack HJ: Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer. Nucl Med Biol 23: 681-684, 1996.
22. Salvatore M and Del-Vecchio S: Dynamic imaging: scintimammography. Eur J Radiol 27(suppl. 2): S259-S264, 1998.
23. Kostakoglu L, Ruacan S, Ergun EL, Sayek I, Elahi N and Bekdik CF: Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIBI uptake in breast cancer. J Nucl Med 39: 1021-1026, 1998.
24. Ciarmiello A, Del-Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, Botti G, D'Aiuto G and Salvatore M: Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 16: 1677-1683, 1998.
25. Barbaries E, Kronauge JF, Cohen D, Davison A, Jones, AG and Croop JM: Characterization of P-glycoprotein transport and inhibition in vivo. Cancer Res 58: 276-282, 1998.
26. Ballinger JR, Bannerman J, Boxen I, Firby P, Hartman NG and Moore MJ: Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. J Nucl Med 37: 1578-1582, 1996.
27. Moretti JL, Azaloux H, Boisseron D, Kouyoumdjian JC and Vilcoq J: Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression. Eur J Nucl Med 23: 980-986, 1996.